Pharmaceutical Composition Containing Botulinum Neurotoxin
A composition, medicament or use, comprising or consisting of botulinum toxin type A2 and a surfactant, having one or more or all of the characteristics selected from the group consisting of; (a) a much longer duration of action; (b) a much faster rate of onset of muscular paralysis; (c) a significantly greater intramuscular safety margin; (d) a selective action on inhibition of skeletal muscle contraction; (e) a selective action on inhibition of pain-related (nociceptive) nerve cell function: Wherein each characteristic is determined comparative to the same characteristic effect of botulinum toxin type A1.
1 - 14 . (canceled)
15 . A method of treatment of a disease, condition, or syndrome selected from the group consisting of: ophtalmological disorders, movement disorders, otorhinolaryngological disorders, gastrointestinal disorders, urogenital disorders, dermatological disorders, pain disorders, inflammatory disorders, secretory disorders, respiratory disorders, hypertrophic disorders, articular disorders, endocrine disorders, autoimmune diseases, proliferative diseases, traumatic injuries and veterinary disorders, said method comprising the step of administering an effective amount of botulinum toxin type A2 to a subject in need thereof.
16 . A method for treatment of cosmetic disorders selected from the group consisting of: skin defects; facial asymmetry; wrinkles selected from glabellar frown lines and facial wrinkles; downturned mouth; and hair loss; said method comprising the administration of an effective dose botulinum toxin type A2 to an area of a subject affected by the cosmetic disorder.